Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Desmopressin Nasal Spray Solution, USP 10mcg/0.1mL (Apotex, USA)
Section 19A approved medicine
Desmopressin Nasal Spray Solution, USP 10mcg/0.1mL (Apotex, USA)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Current
Medicines in short supply/unavailable
MINIRIN desmopressin acetate 10 microgram/ actuation nasal spray - ARTG 59320
Indication(s)
- The treatment of ADH sensitive cranial diabetes insipidus, including treatment of post-hypophysectomy polydipsia and polyuria.
- Nocturnal Enuresis: The symptomatic treatment of primary nocturnal enuresis in patients who have normal ability to concentrate urine. Should be used only in patients who are refractory to the enuresis alarm or in patients in whom enuresis alarm is ontraindicated or inappropriate, and where the oral administration of desmopressin is not feasible.
- Renal Concentrating Capacity: By intranasal administration to adults and children as a diagnostic test to establish renal concentrating capacity.
Images
